CG MedTech Co.,Ltd. (KOSDAQ:056090)
South Korea
· Delayed Price · Currency is KRW 898.00
+14.00 (1.58%)
Mar 18, 2025, 9:00 AM KST
CG MedTech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 34,623 | 34,969 | 41,169 | 38,055 | 27,775 | Upgrade
|
| Other Revenue | -0 | -0 | -0 | - | -0 | Upgrade
|
| Revenue | 34,623 | 34,969 | 41,169 | 38,055 | 27,775 | Upgrade
|
| Revenue Growth (YoY) | -0.99% | -15.06% | 8.18% | 37.01% | -20.22% | Upgrade
|
| Cost of Revenue | 18,834 | 17,139 | 22,518 | 22,571 | 21,932 | Upgrade
|
| Gross Profit | 15,789 | 17,829 | 18,651 | 15,484 | 5,843 | Upgrade
|
| Selling, General & Admin | 12,430 | 13,952 | 12,638 | 10,525 | 11,599 | Upgrade
|
| Research & Development | 3,357 | 4,462 | 4,471 | 4,893 | 4,462 | Upgrade
|
| Other Operating Expenses | 127.64 | 117.83 | 143.14 | 126.68 | 103.54 | Upgrade
|
| Operating Expenses | 16,885 | 15,626 | 28,828 | 16,299 | 16,647 | Upgrade
|
| Operating Income | -1,096 | 2,204 | -10,177 | -815.21 | -10,805 | Upgrade
|
| Interest Expense | -185.71 | -535.88 | -6,317 | -1,294 | -1,242 | Upgrade
|
| Interest & Investment Income | 571.87 | 374.56 | 592.34 | 102.16 | 132.34 | Upgrade
|
| Earnings From Equity Investments | 15.75 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 691.8 | 148.54 | 382.6 | 490.54 | -95.31 | Upgrade
|
| Other Non Operating Income (Expenses) | 141.31 | -262.14 | -3,896 | -160.49 | 73.72 | Upgrade
|
| EBT Excluding Unusual Items | 138.85 | 1,929 | -19,416 | -1,677 | -11,936 | Upgrade
|
| Gain (Loss) on Sale of Investments | -258.52 | -340.46 | 672.25 | 191.93 | -166.86 | Upgrade
|
| Gain (Loss) on Sale of Assets | 132.53 | 261.96 | 165.77 | 23.41 | -5.03 | Upgrade
|
| Asset Writedown | - | -463.9 | - | -3,944 | - | Upgrade
|
| Other Unusual Items | - | - | 156.54 | - | - | Upgrade
|
| Pretax Income | 12.86 | 1,387 | -18,421 | -5,406 | -12,108 | Upgrade
|
| Income Tax Expense | 137.79 | 80.88 | 386.87 | -190.67 | 175.05 | Upgrade
|
| Earnings From Continuing Operations | -124.94 | 1,306 | -18,808 | -5,215 | -12,283 | Upgrade
|
| Minority Interest in Earnings | 184.63 | 323.44 | 268.83 | 244.37 | - | Upgrade
|
| Net Income | 59.69 | 1,629 | -18,540 | -4,970 | -12,283 | Upgrade
|
| Net Income to Common | 59.69 | 1,629 | -18,540 | -4,970 | -12,283 | Upgrade
|
| Net Income Growth | -96.34% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 60 | 78 | 67 | 45 | 38 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 78 | 67 | 45 | 38 | Upgrade
|
| Shares Change (YoY) | -23.05% | 16.59% | 49.47% | 16.01% | 0.40% | Upgrade
|
| EPS (Basic) | 1.00 | 21.00 | -278.64 | -111.66 | -320.10 | Upgrade
|
| EPS (Diluted) | 1.00 | 21.00 | -279.00 | -112.00 | -320.10 | Upgrade
|
| EPS Growth | -95.24% | - | - | - | - | Upgrade
|
| Free Cash Flow | 736.7 | -4,068 | -6,184 | 375.08 | 1,945 | Upgrade
|
| Free Cash Flow Per Share | 12.34 | -52.44 | -92.95 | 8.43 | 50.70 | Upgrade
|
| Gross Margin | 45.60% | 50.99% | 45.30% | 40.69% | 21.04% | Upgrade
|
| Operating Margin | -3.17% | 6.30% | -24.72% | -2.14% | -38.90% | Upgrade
|
| Profit Margin | 0.17% | 4.66% | -45.03% | -13.06% | -44.22% | Upgrade
|
| Free Cash Flow Margin | 2.13% | -11.63% | -15.02% | 0.99% | 7.00% | Upgrade
|
| EBITDA | 596.09 | 4,057 | -7,977 | 1,347 | -8,398 | Upgrade
|
| EBITDA Margin | 1.72% | 11.60% | -19.38% | 3.54% | -30.24% | Upgrade
|
| D&A For EBITDA | 1,692 | 1,853 | 2,201 | 2,162 | 2,406 | Upgrade
|
| EBIT | -1,096 | 2,204 | -10,177 | -815.21 | -10,805 | Upgrade
|
| EBIT Margin | -3.17% | 6.30% | -24.72% | -2.14% | -38.90% | Upgrade
|
| Effective Tax Rate | 1071.82% | 5.83% | - | - | - | Upgrade
|
| Advertising Expenses | 85.15 | 351.37 | 311.16 | 176.3 | 209.98 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.